Phase l Platform
Working group: Clinical trials
Joining forces for Phase l Platform
The phase 1 platform brings together the expertise and knowledge of dedicated early phase clinical trial experts and their resources and facilities. More than 30 years of experience in all parts of early phase clinical trials is combined to actually realize the from ‘bench to bedside’ and translate research into clinical trials. With extensive knowledge on Proof of concept, First in Class and First in Human trials, we can help to overcome challenges in setting-up and running successful phase 1 trials.
CCE’s Phase l platform highlights
- The platform gives pharmaceutical companies access to important opinion leaders with experience in academic early drug development, asset development consulting, and early phase clinical trial protocol design. And the opportunity to have one of their research placed preferentially at one of our experienced centers.
- We have years of experience in partnering with industry ranging from big pharma to small biotech.
- We offer full support on translating research into clinical trials and running early phase clinical trials (protocol development, patient enrollment, submissions, data management, query solving).
- Possibility of finding rare patient segments using molecular characteristics and access to a large number of patients.
- Access to a network of early phase clinical trial specialists and locations with complementary skills and resources that is 100% focused on oncology.
- Contract and budget negotiations in one place.
Meet the team
Dr. Neeltje Steeghs
Leader of the Phase l Platform - The Netherlands Cancer Institute
Dr. Elena Garralda
Member of the Phase I Platform - Vall d’Hebron Institute of Oncology
MD Filippo de Braud
Co-leader of the Phase l Platform - Instituto Nazionale dei Tumori
Dr. Richard Schlenk
Member of the Phase l Platform - Heidelberg University Hospital
Dr. Luigi de Petris
Member of the Phase l Platform - Karolinska Institutet
Dr. Christophe Massard
Member of the Phase l Platform - Gustave Roussy
Dr. Richard Baird
Member of the Phase l Platform - Cambridge Cancer Centre
MSc Sofie Boutkan
Project Manager of the Phase l Platform - The Netherlands Cancer Institute
MEMBERS
7 Renowned European Cancer Centres Collaborate to Advance Cancer Care
Our commitment is to work on advanced cancer research for the benefit of patients
CANCER CORE EUROPE (CCE)